Yet, since the Government has started easing out the lockdown, the demand for open slippers has been improving. Earlier, the company had opened two of its plants and now, in line with the latest guidelines, the company has four functional plants.

The Indian health regulator has granted this licence for emergency use of CytoSorb to treat COVID-19 patients who are major i.e. whose age is greater or equal to 18 years. The licence will be active until the coronavirus outbreak is controlled in the country.

Various ratios are considered before investing in mutual fund schemes. In this article, we will be discussing one of them i.e. information ratio.

Traders would take aggressive bets on the long side only above the high of May 18 (9,158) and on the downside, the level of 8,800 is likely to act as a strong support in the near term. Stocks in news: Bharti Airtel, Kotak Mahindra Bank, Century Plyboards.

Early trends of SGX Nifty suggests a flat to positive start as it is up by 16 points trading at 9,037. But will markets be able to sustain their early gains or would it again be a day with positive start and then giving up their gains is the big question.

On Tuesday, the stock has given a downward sloping channel breakout along with strong volume. Additionally, the stock formed a sizeable bullish candle on the breakout day, which adds strength to the breakout.

Domestic benchmark indices ended the day in a negative territory as Sensex closed at the level of 30,609.30, falling by 63.29 points, which is 0.21 per cent lower than its previous close. Nifty declined by 10.20 points or 0.11 per cent to settle at 9,029.05 levels.

The stock of Apollo Tyres Limited was picked by our Bollinger Band squeeze scanner, which suggests that the stock is near a consolidation breakout.

Bata India Limited (BIL) announced financial results for the quarter ending March 31, 2020. On a year-on-year consolidated basis, the revenue from operations decreased by nine per cent to Rs 620.5 crore in Q4FY20 as against Rs 680.23 crore in the same quarter last year. 

Indoco Remedies announced receipt of approval from United States Food and Drug Administration (USFDA) of its abbreviated new drug application (ANDA) for Succinylcholine Chloride injection USP multi‐dose vial.